SLC41A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.263210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.510560E-01
Normal-vs-Stage2
1.313210E-01
Normal-vs-Stage3
1.426230E-01
Normal-vs-Stage4
4.629700E-02
Stage1-vs-Stage2
8.552400E-01
Stage1-vs-Stage3
5.906400E-01
Stage1-vs-Stage4
7.521400E-01
Stage2-vs-Stage3
6.194200E-01
Stage2-vs-Stage4
8.816800E-01
Stage3-vs-Stage4
7.750200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.104010E-01
Normal-vs-AfricanAmerican
7.258000E-01
Normal-vs-Asian
1.685670E-02
Caucasian-vs-AfricanAmerican
3.958400E-03
Caucasian-vs-Asian
3.103400E-01
AfricanAmerican-vs-Asian
7.702300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.051170E-01
Normal-vs-Female
1.704960E-01
Male-vs-Female
1.731580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.060040E-01
Normal-vs-Age(41-60Yrs)
2.239400E-01
Normal-vs-Age(61-80Yrs)
1.307170E-01
Normal-vs-Age(81-100Yrs)
9.355200E-04
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.669200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.969800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.895920E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.815990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.738700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.762400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.539430E-01
Normal-vs-Daily Drinker
1.362340E-02
Normal-vs-Weekly Drinker
1.198570E-01
Normal-vs-Occasional Drinker
2.846800E-01
Normal-vs-Social Drinker
9.120400E-02
Non Drinker-vs-Daily Drinker
2.301800E-01
Non Drinker-vs-Weekly Drinker
6.620200E-01
Non Drinker-vs-Occasional Drinker
6.156400E-01
Non Drinker-vs-Social Drinker
7.224600E-01
Daily Drinker-vs-Weekly Drinker
8.887600E-02
Daily Drinker-vs-Occasional Drinker
1.149410E-01
Daily Drinker-vs-Social Drinker
4.694600E-01
Weekly Drinker-vs-Occasional Drinker
9.438800E-01
Weekly Drinker-vs-Social Drinker
4.364800E-01
Occasional Drinker-vs-Social Drinker
4.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.357770E-01
Normal-vs-Grade 2
7.811600E-02
Normal-vs-Grade 3
7.653500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.800200E-01
Grade 1-vs-Grade 3
2.372400E-01
Grade 1-vs-Grade 4
1.357770E-01
Grade 2-vs-Grade 3
5.771200E-01
Grade 2-vs-Grade 4
7.811600E-02
Grade 3-vs-Grade 4
7.653500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.158100E-02
Normal-vs-NonDiabetic
9.246000E-02
Diabetic-vs-NonDiabetic
8.400000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.714400E-01
Normal-vs-NoPancreatitis
7.677900E-02
Pancreatitis-vs-NoPancreatitis
6.779400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.809610E-01
Normal-vs-N1
1.174350E-01
N0-vs-N1
9.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.337010E-01
Normal-vs-TP53-NonMutant
4.713000E-01
TP53-Mutant-vs-TP53-NonMutant
3.962500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
